Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4801 to 4815 of 8314 results

  1. Stereotactic ablative radiotherapy compared with surgery: What is the effectiveness and cost effectiveness of stereotactic ablative radiotherapy (SABR) compared with surgery (for example, sublobar, wedge resection, lobectomy) for people with non-small-cell lung cancer (stage I and IIA) in whom surgery is suitable?

    Recommendation ID NG122/2 Question Stereotactic ablative radiotherapy compared with surgery: What is the effectiveness and cost effectiveness

    Research recommendation
    Published
    27 April 2023

  2. Stopping antiviral treatment in HBeAg-negative disease:- Further research should be undertaken to evaluate the clinical and cost effectiveness of hepatitis B surface antigen (HBsAg) quantitative assays in determining treatment duration in hepatitis B e antigen- (HBeAg) negative disease.

    Recommendation ID CG165/1 Question Stopping antiviral treatment in HBeAg-negative disease:- Further research should be undertaken to evaluate

    Research recommendation
    Published
    9 June 2015

  3. Specialist dementia support:- What is the most effective and cost effective way to support people with dementia living at home?

    Recommendation ID NG21/4 Question Specialist dementia support:- What is the most effective and cost effective way to support people with

    Research recommendation
    Published
    13 October 2015

  4. Switching from inpatient intravenous to outpatient oral antibiotic therapy in patients with neutropenic sepsis:- A randomised controlled trial should be undertaken to evaluate the clinical and cost effectiveness of stopping intravenous antibiotic therapy and switching to oral therapy within the first 24 hours of treatment in patients with neutropenic sepsis who are having treatment with intravenous antibiotics. The outcomes to be measured are overtreatment, death, need for critical care, length of hospital stay, duration of fever and quality of life.

    Recommendation ID CG151/5 Question Switching from inpatient intravenous to outpatient oral antibiotic therapy in patients with neutropenic

    Research recommendation
    Published
    9 June 2015

  5. Stopping preventive medicines:- What is the clinical and cost effectiveness of stopping preventive medicines in people with multimorbidity who may not benefit from continuing them?

    Recommendation ID NG56/3 Question Stopping preventive medicines:- What is the clinical and cost effectiveness of stopping preventive medicines

    Research recommendation
    Published
    18 October 2016

  6. Specialist investigation:- What specialist investigations should be conducted to exclude a diagnosis of functional dyspepsia in people with uninvestigated dyspepsia that does not respond to PPIs or H2 receptor antagonists (H2RAs) despite optimum primary care?

    Recommendation ID CG184/5 Question Specialist investigation:- What specialist investigations should be conducted to exclude a diagnosis

    Research recommendation
    Published
    9 June 2015

  7. Which patients, other than those known to have a high risk of complications or mortality, would benefit from postoperative care in a specialist recovery area (a high-dependency unit, a post-anaesthesia care unit or an intensive care unit)?

    Recommendation ID NG180/5 Question Which patients, other than those known to have a high risk of complications or mortality, would benefit

    Research recommendation
    Published
    26 October 2020

  8. Stopping rules for antiangiogenic treatment for late AMD (wet):- When should anti-vascular endothelial growth factor (VEGF) treatment be suspended or stoppedin people with late AMD (wet)?

    Recommendation ID NG82/3 Question Stopping rules for antiangiogenic treatment for late AMD (wet):- When should anti-vascular endothelial

    Research recommendation
    Published
    13 November 2018

  9. What are the symptoms of GORD in infants, children and young people with a neurodisability?

    Recommendation ID NG1/1 Question What are the symptoms of GORD in infants, children and young people with a neurodisability? Any

    Research recommendation
    Published
    15 November 2019

  10. Specific versus generic CBT for children and young people with social anxiety disorder:- What is the clinical and cost effectiveness of specific CBT for children and young people with social anxiety disorder compared with generic anxiety-focused CBT?

    Recommendation ID CG159/2 Question Specific versus generic CBT for children and young people with social anxiety disorder:- What is the

    Research recommendation
    Published
    9 June 2015

  11. Strategies to slow the progression of age-related macular degeneration (AMD):- What is the effectiveness of antioxidant and zinc supplements on AMD disease progression for people with early AMD at high risk of progression in the context of a randomised controlled trial?

    Recommendation ID NG82/1 Question Strategies to slow the progression of age-related macular degeneration (AMD):- What is the effectiveness

    Research recommendation
    Published
    13 November 2018

  12. What structured group activities are effective at improving interpersonal functioning (social skills) for people with complex psychosis?

    Recommendation ID NG181/4 Question What structured group activities are effective at improving interpersonal functioning (social skills)

    Research recommendation
    Published
    26 October 2020

  13. What tailored interventions (pharmaceutical and psychological) specific to rehabilitation are effective at equipping people with complex psychosis with the ability to live in the community?

    Recommendation ID NG181/10 Question What tailored interventions (pharmaceutical and psychological) specific to rehabilitation are effective

    Research recommendation
    Published
    26 October 2020

  14. Studies exploring the effectiveness of bevacizumab in people previously treated with a taxane and its effects on health-related quality of life.

    Recommendation ID TA263/1 Question Studies exploring the effectiveness of bevacizumab in people previously treated with a taxane and its

    Research recommendation
    Published
    9 June 2015

  15. How effective and cost effective are education-based alcohol interventions targeted at children and young people aged 11 to 25 with SEND who are thought to be vulnerable to alcohol misuse?

    Recommendation ID NG135/4 Question How effective and cost effective are education-based alcohol interventions targeted at children and

    Research recommendation
    Published
    25 October 2019